Searched for
DICLOFENAC SODIUM
Over 160 drug samples found sub-standard in DecemberA recent inspection by India's drug regulator has revealed a troubling statistic: 167 medication samples were classified as not of standard...- Paracetamol to PAN-D: CDSCO finds over 50 sub-standard drugs. Check full list of medicinesThe Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...
- 40 medical devices, bulk drug units take off under PLIMinister for Chemicals and Fertilisers Mansukh Mandaviya said the country has taken a big step towards self-reliance, with the commissionin...
- Business and valuation tailwinds to help in outperformance? 5 Indian pharma stocks with upside potential of up to 32%Just before the whole market was consumed by the PSU rally, one sector that came into the limelight after many years of underperformance wa...
- NPPA fixes retail prices of 23 drug formulationsSimilarly, the retail price of one tablet of Telmisartan, Chlorthalidone & Cilnidipine tablets at Rs 13.17. The retail price of one tablet ...
- On a path to recovery; 5 mid-cap pharma stocks with an upside potential up to 41%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in bearish markets. Some of them are mid-sized Ind...
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...
- Stocks in news: Airtel, BSE, Adani Green, Ambuja Cements, AstralBharti Airtel Ltd reported a sharp 92% year-on-year (YoY) rise in consolidated net profit for the December quarter to Rs 1,588 crore. Reven...
- Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when m...
- Lupin launches generic joint pain drug in US marketThe company's product -- Diclofenac Sodium Topical Solution 2 per cent -- is the generic version of Horizon Pharma Therapeutics Pennsaid, L...
- Dr Reddy's launches generic arthritis drug in US market"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our con...
- Buy Cipla, target Rs 720: SharekhanBuy Cipla Ltd. at a price target of Rs 720.
- Glenmark gets USFDA nod for skin lesion treatment gelThe company's current portfolio consists of 110 products authorised for distribution in the US marketplace and 61 Abbreviated New Drug Appl...
- Government caps price of 18 formulation packsAs per the notification, the prices of formulations including Diclofenac Sodium, Clotrimazole, Mesalamine, Omeprazole+Domperidone and Vanco...
- In a major pain relief, court upholds Troikaa’s drug patent Of generic drugPharma cos building blockbuster brands of generic drugs can rest easy. In a landmark judgement, Gujarat HC has upheld the design patent of ...
- World's first vulture to be born in captivity survivesIn a good news for the endangered species of vulture, the Vulture Conservation Breeding Centre in Pinjore has achieved a rare feat wherein ...
- Novartis gets DGCI nod to import diclofenac sodiumDrug maker Novartis Healthcare has received licence from the Drugs Controller General of India (DGCI) to import analgesic drug diclofenace ...
- Variation in bulk, retail prices to nail pharmasDrug makers governments will soon face tough questions from the drug price regulator.
- States prescribe control pill for pharmasPopular drugs for treating bacterial infection, allergy and inflammation - on which chemists take huge margins and make them 20 times costl...
- Generics market may lose value on margin cutThe proposed trade margin cut on generic drugs from October 2 is set to be applicable to 2,000 brands of specified strengths, and as a resu...
Load More
